Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Generic Drug Name to...

    Generic Drug Name to be two font larger than Brand Name: New Labelling Rules

    Written by Ruby Khatun Khatun Published On 2018-01-27T13:56:52+05:30  |  Updated On 27 Jan 2018 1:56 PM IST
    Generic Drug Name to be two font larger than Brand Name: New Labelling Rules

    New Delhi: Labeling rules for generic drugs are going to become stringent on order to endorse low-cost generic medicines as the health ministry is soon going to come out with a notification, making it compulsory for pharma companies to carry the generic names of drugs in letters that are two font sizes larger than the brand name.


    As per a recent Mint report ,once notified under the Drugs and Cosmetics Act, any violation will be punishable under the law.


    Fixed-dose combinations (FDCs) of vitamins and other drugs containing three or more drugs, will be exempted from the new labeling rules.


    Speaking with Mint, a person having direct knowledge of the matter said, “For vitamins and FDCs containing three or more drugs, the brand name or the trade name shall be written in brackets below or after the proper name. The rest of the packs of drugs shall carry the proper name of the drug or fixed-dose combination drug at least two fonts larger than the brand name or the trade name.”


    A modification to Rule 96 of the Drugs and Cosmetics Act had been approved by the Drug Technical Advisory Board (DTAB) that sought changes in the labeling of drugs to boost generic drugs as Rule 96 deals with the manner of labeling drugs.


    Last year, in its presentation to the health ministry, the Indian Drug Manufacturers Association (IDMA), a pharmaceuticals lobby group said that putting the brand name or trade name in brackets on packs will only add to the confusion and the part of the proposal is unlikely to serve any purpose from a consumer perspective.


    IDMA said, “The brand name or trade name to be written in brackets below or after the proper name does not seem to be necessary as it only adds to confusion in interpretation. We are of the view that the requirement of displaying brand name in brackets is not likely to bring in any qualitative change and is not likely to serve any purpose from the consumer perspective.”


    The government has been pushing for generic drugs for a while now and its efforts gained momentum with Prime Minister Narendra Modi announcing plans to put in place a legal framework in April last year to ensure doctors prescribe generic medicines.


    The Medical Council of India (MCI) had also issued orders in 2016 to all central and state government hospitals asking them to ensure that doctors write out prescriptions with generic names of medicines.


    Read Also : Prescribe only Generic Drugs or Face Action: MCI - Medical Dialogues
    To push the use of low-cost generic medicines, even the draft pharmaceutical policy last year had proposed that public procurement and dispensing of medicines should be of generic drugs bearing names of salts. The draft suggested a major shift where only the name of salts (active ingredients) would be displayed on the package.

    “Branded generic drugs are currently sold like other patented medicines, with their brand names displayed on the packaging. A manufacturer will only be allowed to stamp the company name and the generic name on the packaging and not the brand name,” the draft had proposed.

    Drug Technical Advisory BoardDrugs and Cosmetics ActFDCfixed dose combinationsgeneric drugsgovernmentHealth MinistryIndian Drug Manufacturer's Associationlabeling rulesMCIMedical Council of Indiastringent
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok